
When Treatment Works, but the Numbers Don't - Pierre Sujobert
This episode examines the gap between improving survival and continuing disease burden in hematological malignancies. Dr Pierre Sujobert discusses with host Dr Charles de Bock epidemiological patterns across hematological malignancies, including rising incidence in multiple myeloma, non-Hodgkin lymphomas, and acute myeloid leukemia. He also considers environmental and occupational exposures, the value of locally focused research, and the importance of taking patients’ work histories seriously. This episode is relevant to hematology researchers and clinicians studying treatment outcomes, prevention, and population health. Original article: Therapeutic success and epidemiological failure in hematology SEER Data & Software: https://seer.cancer.gov/data-software/ Thoughts on the podcast? Fill out our feedback form. 00:00 - Introducing the guest and the epidemiological paradox 04:12 - What SEER data reveal about survival, incidence, and mortality 06:08 - Five patterns across hematological malignancies 09:01 - Diagnostic bias and how far U.S. data can be generalized 12:01 - Environmental and occupational exposures behind rising incidence 14:53 - Local research and the role of hematologists in pesticide advocacy 18:12 - Why clinicians should document patients’ occupational histories 21:19 - Measuring environmental risk and interpreting a risk of 1.4 23:31 - Research opportunities: glyphosate, microbiota, and cancer biology 26:50 - Why prevention and treatment should go hand in hand 29:31 - Writing about science, advocacy, and public health